R1 RCM, a revenue cycle management service provider, ended fiscal year 2017 with a $58.8 million net loss, compared to net income of $177.1 million reported in fiscal year 2016. Here are four things ...

R1 RCM has received a noncompliance notice from Nasdaq’s Listing Qualifications Department resulting from R1’s delay in filing its quarterly report on Form 10-Q for the third quarter of 2023. Nasdaq’s ...

Update 4:30pm: Updates shares, adds comment from R1 RCM holder. R1 RCM (NASDAQ:RCM) jumped 25% after New Mountain offered to buy the company for $13.75 a share in a cash. New Mountain also requested ...

MURRAY, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of ...

R1 RCM (NASDAQ:RCM) fell 3% at least partly amid a report that one of its customers hospital computer networks was hit with a cyberattack. Ascension hospitals in Michigan and across the U.S. were hit ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of R1 RCM Inc. (NASDAQ: RCM) to investment funds affiliated with TowerBrook Capital Partners ...

MURRAY, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), announced today a 10-year partnership with St. Clair Health to serve as its primary provider of end-to-end revenue ...

R1 RCM supports healthcare companies with technology-driven billing services. It saw revenue rise by 31% year over year in the third quarter, but net income fell. The company purchased Cloudmed in ...

Voss Capital, LLC an investment management company, released its first-quarter 2024 investor letter. A copy of the letter can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the ...

If you’re not getting patients in the door, you’re not getting revenue. That was part of the logic prompting revenue-cycle management firm R1 RCM Inc. to spend $190 million to buy SCI Solutions Inc., ...

(Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 ...